SMA News Today is providing live coverage of the MDA Clinical & Scientific Conference taking place March 16-19 in Dallas. Stay tuned to this page for all the latest news.
Treatment with Spinraza (nusinersen) can help stabilize motor function in adults with spinal muscular atrophy (SMA), according to a new analysis. “This study aligns with previously reported findings and suggests that long-term [treatment with Spinraza] offers sustained clinical benefits in adults with SMA,” researchers wrote in the abstract…
Recent Posts
- MDA 2026: Keynote speaker to MDA community: ‘Your voice is powerful’
- Ahead of this year’s MDA Conference, association’s CEO speaks of ‘hope’
- MDA 2025: Potassium channel could be SMA treatment target
- MDA 2025: Apitegromab safely improves SMA motor function
- MDA 2025: Evrysdi consistent after 5-year SUNFISH follow-up
